Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vanessa Fernanda Moreira Ferreira, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Vanessa Fernanda Moreira Ferreira's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Vanessa Fernanda Moreira Ferreira has written about over time.
Demyelinating Diseases, 1 publications between 2019 and 2019, average publication date June 2019. Immunologic Factors, 1 publications between 2019 and 2019, average publication date June 2019. Multiple Sclerosis, Relapsing-Remitting, 1 publications between 2019 and 2019, average publication date June 2019. Adult, 2 publications between 2019 and 2020, average publication date December 2019. Methylprednisolone, 1 publications between 2020 and 2020, average publication date May 2020. Serum Sickness, 1 publications between 2020 and 2020, average publication date May 2020. Humans, 3 publications between 2019 and 2023, average publication date March 2021. Male, 2 publications between 2019 and 2023, average publication date August 2021. Female, 2 publications between 2020 and 2023, average publication date January 2022. Intermediate Filaments, 1 publications between 2023 and 2023, average publication date September 2023. Magnetic Resonance Imaging, 1 publications between 2023 and 2023, average publication date September 2023. Multiple Sclerosis, 1 publications between 2023 and 2023, average publication date September 2023. Neurofilament Proteins, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Moreira Ferreira's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.